Status:
UNKNOWN
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Collaborating Sponsors:
Fondazione Progetto Ematologia
Conditions:
Idiopathic Thrombocytopenic Purpura
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the study is to produce a dynamic picture of the adult ITP natural history and management in Italy by collecting standardized information retrospective and prospective data of patient...
Detailed Description
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder affecting both children and adults, characterized by a platelet count below 100 x 109/L in the absence of any underlying diseas...
Eligibility Criteria
Inclusion
- Patients never treated before for whom an ITP treatment is initiated for the first time by the recruiting center
- Patients already treated for whom a new line of ITP treatment is initiated by the recruiting center (the patients could have been treated elsewhere before)
- Patients who, under any ITP treatment at the recruiting center.
Exclusion
- Undefined
Key Trial Info
Start Date :
October 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
861 Patients enrolled
Trial Details
Trial ID
NCT03465020
Start Date
October 15 2018
End Date
July 1 2023
Last Update
July 20 2022
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Sc Ematologia E Centro Trapianti Midollo Osseo
Parma, SC, Italy
2
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica
Ancona, Italy
3
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
Bari, Italy
4
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia
Bologna, Italy